I think the payment from Amgen will depend on what they learned in the data room not the current SP. If the signed and pending contracts are as significant as we have been lead to believe then the current SP is low and Amgen will pay significantly more.
We may see the announcement of a successful conclusion, another extension or that Amgen has terminated negotiations all together. I think another extension or successful outcome are equally possible. The original Amgen announcement was first made on the ASX Monday pre-market and I would expect this next announcement will be made the same way.
UNS Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held